Biotech

Stämm, an Argentine developer of bioreactor equipment, raised a USD17m Series A from Varana, Vista, New Abundance, Trillian, Serenity Traders and Decarbonization Consortium, with follow-on from Draper Cygnus, Draper Associates,…

KawiSafi Ventures les a USD15.5m Series B for Sistema.bio, a Mexico-based developer of biodigester energy for agricultural producers, with participation from AXA IM Impact Investing, and follow-on from Engie RDE,…

BRZ Investimentos-backed Vittia Fertilizantes, a Brazilian biotechnology and agricultural inputs company, raised BRL436m in its IPO on the B3.  BRZ exited via a secondary offering that represented roughly 70% of…

Draper Cygnus invested US$640k in Panarum, an Argentine biotech developing nano capsules to replace the use of needles with pill-based treatments. (Press Release) – It is quite likely that you…

CITES invested US$1.75m in each of three Argentine early-stage startups: Stradot, a hardware startup building drones to lift and organize parked vehicles in outdoor parking lots; Clover, a biotech startup…

Uruguay-based biotech Eolo Pharma raised a US$2.7m Series A from CITES and a group of international investors to fund preclinical trials for an obesity treatment. Eolo Pharma is run by…

Unima is a Mexico-based healthtech startup developing fast and low-cost diagnostics and infectious disease surveillance for limited resource settings. LAVCA interviewed Laura Mendoza, Co-Founder & CPO about biotechnology, impact of winning WeXchange’s pitch competition…

Aurus Capital led an undisclosed Series A investment in Aguamarina, a Chilean industrial biotech company focused on sustainable solutions for the mining industry, with participation from Khosla Ventures and Endeavor…

Invermaster Ventures co-led a US$1m investment in Chilean biotech Levita Magnetics. Existing investors include Alex Seelenberger from Aurus Capital (co-founder and first investor), FEN Ventures (Cristóbal Silva and José Antonio…

Carao Ventures led a US$2m follow-on investment in Speratum, a Costa Rican biotech focused on microRNA-directed oncology therapies primarily for pancreatic and ovarian cancers. Carao previously invested US$800k when Speratum…